RNAi as an Intercellular Antiviral Defense Mechanism

RNA干扰(RNAi)是一种双链RNA(DsRNA)引导的调节序列的机制 RNA的特异性降解。最近证明RNA干扰可以用来抑制病毒 复制开创了一个令人兴奋的研究领域。首先，它提供了一种新的抗病毒治疗方法 其次，它可能构成了一种迄今尚未被认识的天然抗病毒防御机制。长期的 这项提议的目的是更好地理解RNA的意义和治疗潜力。 干扰(RNAi)抑制病毒感染。为此，我们提出了三个具体目标：(1) 了解基于siRNA的病毒抑制的决定因素；(2)研究RNAi作为一种天然的抗病毒药物 防御机制；以及(3)识别和表征RNAi机制的新组件。我们会 使用特征良好的正链RNA病毒(小核糖核酸病毒、甲型病毒和黄病毒)作为 模型病毒，并使用果蝇和哺乳动物细胞作为模型宿主。 (1)为了了解基于siRNA的病毒抑制的决定因素，我们将定义 对RNAi敏感的RNA病毒，并探索不同siRNA设计方法的效率。 我们还将调查病毒逃避RNAi的能力。(2)研究RNAi作为一种天然抗病毒药物 防御机制，我们检测病毒感染动物细胞是否产生siRNA，并分析 RNAi机制的抑制成分是否促进哺乳动物细胞中的病毒复制。我们会 还要确定病毒感染是否会导致RNAi机制的变化。(3)识别和 为了表征RNAi机制的新组件，我们在果蝇中进行了全基因组筛选 细胞。然后我们将使用细胞生物学和生物化学来表征进入的机制和作用 ，并分离出RNAi进入元件的哺乳动物同源基因 并探索它们在哺乳动物系统中的RNAi进入中的作用。

RNA interference (RNAi) is a double-stranded RNA (dsRNA) guided mechanism that mediates sequence specific degradation of RNA. The recent demonstration that RNA interference can be used to inhibit virus replication has initiated an exciting field of research. First, it provides a novel antiviral therapeutic approach and, second, it may constitute a hitherto unrecognized natural antiviral defense mechanism. The long-term goal of this proposal is to gain a better understanding of the significance and therapeutic potential of RNA interference (RNAi) in the inhibition of viral infections. To this end we propose three specific aims to: (1) understand the determinants of siRNA-based viral inhibition; (2) investigate RNAi as a natural antiviral defense mechanism; and (3) identify and characterize novel components of the RNAi machinery. We will employ well-characterized positive stranded RNA viruses (picornaviruses,alphaviruses, and flaviviruses) as model viruses, and employ Drosophila and mammalian cells as model hosts. (1) To understand the determinants of siRNA-based viral inhibition, we will define the genome regions of RNA viruses that are susceptible to RNAi, and explore the efficiency of different siRNA design approaches. We will also investigate the ability of viruses to escape RNAi. (2) To investigate RNAi as a natural antiviral defense mechanism, we examine whether viral infection of animal cells produces siRNAs and analyze whether inhibiting components of the RNAi machinery enhances viral replication in mammalian cells. We will also determine whether viral infection induces changes in the RNAi machinery. (3) To identify and characterize novel components of the RNAi machinery, we carry out genome-wide screens in Drosophila cells. We will then employ cell biology and biochemistry to characterize the mechanism of entry and the role of the genes identified in our screens, and isolate the mammalian orthologs of RNAi entry components identified in our screens and explore their role in RNAi entry in mammalian systems.